ERD

2.4 Utility of new prime-target immunisation approaches in liver-stage protective immunity in mice

Project: OptiMalVax

Updated at: 30-10-2023

Show more information

Project acronym OptiMalVax

A Reproducible and Scalable Process for Manufacturing a Pfs48/45 Based Plasmodium falciparum Transmission-Blocking Vacci...

Project: OptiMalVax

Updated at: 30-10-2023

Show more information

Project acronym OptiMalVax

Alpha-v–containing integrins are host receptors for the Plasmodium falciparum sporozoite surface protein, TRAP

Project: OptiMalVax

Updated at: 30-10-2023

Show more information

Project acronym OptiMalVax

A Universal Plug-and-Display Vaccine Carrier Based on HBsAg VLP to Maximize Effective Antibody Response

Project: OptiMalVax

Updated at: 30-10-2023

Show more information

Project acronym OptiMalVax

Human Antibodies that Slow Erythrocyte Invasion Potentiate Malaria-Neutralizing Antibodies

Project: OptiMalVax

Updated at: 30-10-2023

Show more information

Project acronym OptiMalVax

7.6 Report on efficacy against sporozoite challenge of prime-target immunisation in healthy volunteers

Project: OptiMalVax

Updated at: 30-10-2023

Show more information

Project acronym OptiMalVax

4.1 Identification of new novel candidates from natural blockers and proteomic screen

Project: OptiMalVax

Updated at: 30-10-2023

Show more information

Project acronym OptiMalVax

2.3 Rank ordering of the protective efficacy of new liver-stage antigen candidates

Project: OptiMalVax

Updated at: 30-10-2023

Show more information

Project acronym OptiMalVax

4.3 Generate VLPs for two TBV candidates and assess immunogenicity/TB

Project: OptiMalVax

Updated at: 30-10-2023

Show more information

Project acronym OptiMalVax

3.4 Efficacy of new candidate blood-stage antigens

Project: OptiMalVax

Updated at: 30-10-2023

Show more information

Project acronym OptiMalVax

5.1 generation of five new VLPs with SnoopCatcher and SpyCatcher

Project: OptiMalVax

Updated at: 30-10-2023

Show more information

Project acronym OptiMalVax

Screening of viral-vectored P. falciparum pre-erythrocytic candidate vaccine antigens using chimeric rodent parasites

Project: OptiMalVax

Updated at: 30-10-2023

Show more information

Project acronym OptiMalVax

Preclinical development of a Pfs230-Pfs48/45 chimeric malaria transmission-blocking vaccine

Project: OptiMalVax

Updated at: 30-10-2023

Show more information

Project acronym OptiMalVax

4.5 Assess immunogenicity and TBA of bivalent VLPs to select candidate for GMP manufacture

Project: OptiMalVax

Updated at: 30-10-2023

Show more information

Project acronym OptiMalVax

1.3 Generation of lead bivalent sporozoite VLP suitable for progression to GMP

Project: OptiMalVax

Updated at: 30-10-2023

Show more information

Project acronym OptiMalVax

1.4 Generation of 8 new vectored vaccine candidates

Project: OptiMalVax

Updated at: 30-10-2023

Show more information

Project acronym OptiMalVax

Heterologous Expression and Evaluation of Novel Plasmodium falciparum Transmission Blocking Vaccine Candidates

Project: OptiMalVax

Updated at: 30-10-2023

Show more information

Project acronym OptiMalVax

7.5 Report on safety and immunogenicity of vectored prime-target immunisation in healthy volunteers

Project: OptiMalVax

Updated at: 30-10-2023

Show more information

Project acronym OptiMalVax

1.5 Generation of 8 transgenic P berghei parasites expressing novel P falciparum antigens

Project: OptiMalVax

Updated at: 30-10-2023

Show more information

Project acronym OptiMalVax

2.1 Liver-stage antigens identified from HLA molecules of parasitized hepatocytes

Project: OptiMalVax

Updated at: 30-10-2023

Show more information

Project acronym OptiMalVax

10.2 Establish relevant committees including PSC, PMMC, ISAC

Project: OptiMalVax

Updated at: 30-10-2023

Show more information

Project acronym OptiMalVax

5.2 Adequate process for lead novel VLPs for initial GMP production

Project: OptiMalVax

Updated at: 30-10-2023

Show more information

Project acronym OptiMalVax

6.4 Preclinical studies completed for adjuvant

Project: OptiMalVax

Updated at: 30-10-2023

Show more information

Project acronym OptiMalVax

Periodic Reporting for period 4 - OptiMalVax (Optimizing a deployable high efficacy malaria vaccine)

Project: OptiMalVax

Updated at: 24-02-2023

Show more information

Project acronym OptiMalVax

Resources